R&D Systems™ Recombinant Human UCH-L5/UCH37 Protein, CF

Catalog No.
E327025	25μg

Catalog No. E327025 Supplier R&D Systems™ Supplier No. E327025

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Reaction conditions will need to be optimized for each specific application. We recommend an initial recombinant human UCH-L5 concentration of 20-100 nM when using Ubiquitin-AMC or Ubiquitin-Rh110 substrates (U-550, U-555)

Specifications

• Accession Number: Q9Y5K5
• For Use With (Application): Bioactivity
• Formulation: X mg/mL (X μM) in 50 mM HEPES pH 7.5, 200 mM NaCl, 1 mM TCEP, 10% (v/v) Glycerol
• Gene ID (Entrez): 51377
• Molecular Weight (g/mol): M.W. (theoretical): 38 kDa
• Quantity: 25 μg
• Source: E. coli-derived human UCH-L5/UCH37 protein
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -70°C as supplied. 3 months, -70°C under sterile conditions after opening.
• Gene Alias: CGI-70, EC 3.4.19.12, INO80 complex subunit R, INO80R, ubiquitin carboxyl-terminal esterase L5, ubiquitin carboxyl-terminal hydrolase isozyme L5, ubiquitin carboxyl-terminal hydrolase L5, Ubiquitin C-terminal hydrolase UCH37, Ubiquitin thioesterase L5, UCH37, UCH37CGI-70, UCHL5, UCH-L5
• Common Name: UCH-L5/UCH37
• Gene Symbol: UCHL5
• Biological Activity: Reaction conditions will need to be optimized for each specific application. We recommend an initial recombinant human UCH-L5 concentration of 20-100 nM when using Ubiquitin-AMC or Ubiquitin-Rh110 substrates (U-550, U-555)
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Expression System: E. coli-derived
• Purity or Quality Grade: >90%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain.
• Protein: UCH-L5/UCH37